Back to User profile » Dr Charles Glueck
Papers published by Dr Charles Glueck:
Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy
Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P
Vascular Health and Risk Management 2017, 13:247-253
Published Date: 6 July 2017
Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
Dixon SG, Bruce CT, Glueck CJ, Sisk RA, Hutchins RK, Jetty V, Wang P
Clinical Ophthalmology 2016, 10:1479-1486
Published Date: 9 August 2016
Retinal artery and vein thrombotic occlusion during pregnancy: markers for familial thrombophilia and adverse pregnancy outcomes
Kurtz WS, Glueck CJ, Hutchins RK, Sisk RA, Wang P
Clinical Ophthalmology 2016, 10:935-938
Published Date: 23 May 2016
Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity
Schockman S, Glueck CJ, Hutchins RK, Patel J, Shah P, Wang P
Clinical Ophthalmology 2015, 9:591-600
Published Date: 3 April 2015